Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Liniecki J"'
Publikováno v:
Nuclear medicine communications. 16(9)
Ytterbium-169 ( 169 Yb) cis-dichlorodimethionine platinum ( 169 Yb-PtCl 2 Meth 2 ) is a new agent of low toxicity with an affinity for neoplastic tumours. The aim of this study was to assess the diagnostic value of 169 Yb-PtCl 2 Meth 2 scintigraphy i
Autor:
Mattsson, S., Johansson, L., Liniecki, J., Nosske, D., Stabin, M., Leide-Svegborn, S., Taylor, D.
Publikováno v:
World Congress on Medical Physics & Biomedical Engineering, September 7 - 12, 2009, Munich, Germany (9783642039010); 2009, p474-477, 4p
Publikováno v:
Radiation Protection Dosimetry; 2003, Vol. 105 Issue 1-4, p587-591, 5p
Publikováno v:
International Urology & Nephrology; Dec1981, Vol. 13 Issue 4, p321-331, 11p
Publikováno v:
Journal of Medical Physics; Jul1986, Vol. 11 Issue 3, p473-476, 4p
Publikováno v:
Nuclear Medicine Communications; Sep1995, Vol. 16 Issue 9, p747-755, 9p
Publikováno v:
Nuclear Medicine Communications; Aug1994, Vol. 15 Issue 8, p628-635, 8p
Publikováno v:
Nuklearmedizin. 22:159-161
Tumor and normal tissue uptake of 51Cror 57Co-labelled bleomycin (BLEO) and tallysomycin (TLM) was compared in female solid Ehrlich ascites tumor mice of Swiss strain. The complexes were administered intraperitoneally: 30-50 μ§ of each complex with
Publikováno v:
Nuklearmedizin. 23:127-129
SummaryConcentrations were studied of 58Co in the solid Ehrlich ascites tumour, blood, muscle and bone of male Swiss mice administered as complexed with total bleomycin commercially available and its isolated fractions A2, B2, demethyl A2, A1, A5, B4
Publikováno v:
Nuklearmedizin. Nuclear medicine; May 1986, Vol. 25 Issue: 5 p188-193, 6p